Baccharis trimera
Baccharis trimera · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Baccharis trimera is a versatile medicinal plant recognized for its significant therapeutic potential in various health applications. It contains valuable bioactive compounds, including echinocystic acid, rutin, and saponins, which contribute to its diverse pharmacological profile. Due to its potent analgesic activities, it is frequently utilized in the management of conditions such as cutaneous leishmaniasis, diabetes mellitus, and various gastrointestinal disorders. These medicinal benefits can be accessed through several preparations, ranging from medicinal teas to aqueous and hydroethanolic extracts. Understanding these chemical properties and preparation methods is essential for leveraging the plant's full healing capacity.
- Synonyms
- Baccharis Genistelloides Var. Trimera · Molina Trimera · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Baccharis trimera is a versatile plant known by a diverse array of regional names. It is frequently referred to by its common name, Carqueja, in many traditional botanical contexts. In certain areas, it is more specifically identified as Carqueja-verdadeira to distinguish it from similar species. This plant is also widely recognized by the name Chilca among various local populations. Furthermore, it holds a significant cultural identity under the name Jaguarete ka'a.
Sources: Catalogue of Life (COL)
Synonyms
Baccharis trimera is a botanical species that is frequently identified through several different taxonomic names. Within scientific literature, it is often listed under the synonym Baccharis genistelloides var. trimera. Researchers also recognize the variety known as Baccharis trimera var. carqueja when classifying this plant. Furthermore, the name Molina trimera serves as another recognized synonym for the species. Understanding these overlapping designations is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Baccharis trimera belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its evolutionary connections to other flowering plants. This specific plant is a member of the genus Baccharis, which helps define its unique botanical characteristics. Finally, it is categorized within the Asteraceae family, placing it among the well-known composites.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Baccharis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Baccharis trimera is a plant species widely distributed across the diverse landscapes of Southern America. Its presence is particularly notable throughout Brazil, spanning various regions including the south. The species also flourishes in Southern South America, with significant populations found in both the northeast and northwest of Argentina. Furthermore, its range extends into neighboring countries such as Paraguay and Uruguay. This broad geographical footprint highlights the plant's ability to thrive within multiple South American ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Baccharis trimera is characterized by its distinct subshrub growth form. This resilient plant remains entirely self-supporting as it develops throughout its life cycle.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Baccharis trimera has demonstrated significant therapeutic potential through its notable analgesic and anti-inflammatory activities. Research indicates that a butanolic fraction derived from the plant's aerial parts can markedly inhibit inflammation and pain responses in various animal models. Specifically, the extract showed a powerful ability to reduce abdominal constrictions, reaching an inhibition rate of up to 95.1% at higher doses. These medicinal effects appear to stem from the plant's ability to inhibit prostaglandin biosynthesis. Detailed chromatographic analysis suggests that these beneficial properties are primarily driven by active constituents such as rutin and saponins.
Compounds
Baccharis trimera is a plant known for its diverse chemical profile and significant therapeutic potential. Research indicates that the plant contains various beneficial compounds, including a variety of flavonoids. Specifically, the presence of rutin within its extracts contributes to its biological activities. Furthermore, the plant is characterized by its saponins, which serve as major active constituents. Within these saponins, echinocystic acid has been identified as a primary aglycone responsible for much of its medicinal efficacy.
Conditions
Baccharis trimera demonstrates significant therapeutic potential by treating C16-paf-induced swelling through its anti-inflammatory properties. The plant's inulin-type fructans provide hepatoprotection by treating CCl4-induced injuries in the liver. Furthermore, its ethanol-soluble fraction effectively treats cardiac and renal histopathological changes in models involving multiple cardiovascular risk factors. The plant also shows promise in combating infectious diseases, as its derivatives can treat Leishmania amazonensis with high selectivity. Finally, the essential oil of the species exhibits potent schistosomicidal activity to treat Schistosomiasis by inducing mortality and tegument destruction in adult worms.
Preparations
Baccharis trimera is prepared as a hydroethanolic extract to promote gastroprotection and the healing of gastric ulcers. In folk medicine, the plant is commonly prepared as medicinal teas to treat inflammatory processes and liver diseases. Researchers also utilize an aqueous extract of the plant to study its anti-inflammatory and immunomodulatory effects. Furthermore, the plant is processed into an aqueous crude extract for various biological assessments. Finally, a specific butanolic fraction known as BT-II is derived from this aqueous crude extract to evaluate its analgesic and anti-inflammatory properties.